Altre lingue Intra-Cellular Therapies, Inc.

Azioni

ITCI

US46116X1019

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
72 ^USD	-6,12%		+5,93%	+0,53%

17/04	INTRA-CELLULAR THERAPIES, INC. : Goldman Sachs rimane Neutral	ZM
17/04	INTRA-CELLULAR THERAPIES, INC. : BofA Securities rimane Buy	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Intra-Cellular Therapies Prices $500 Million Stock Offering	18/04
Intra-Cellular Therapies Prices Public Offering of Common Stock	18/04
Intra-Cellular Therapies Launches $500 Million Public Offering of Stock; Shares Edge Lower in Late Trade	16/04
UnitedHealth Group, Morgan Stanley rise; PNC Financial, Live Nation fall, Tuesday, 4/16/2024	16/04
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock	16/04
Sector Update: Health Care Stocks Higher Late Afternoon	16/04
Top Midday Gainers	16/04
US Stocks Lacking Direction Prior to Powell Remarks, Investors Looking for Signs of Future Rate Cuts by Federal Reserve	16/04
Intra-Cellular Therapies Stock Jumps After Major Depressive Disorder Treatment Study Shows Positive Results	16/04
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder	16/04
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder	16/04
Intra-Cellular Therapies CFO Hineline Retiring, Promotes Halstead to President	19/03
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes	19/03
Intra-Cellular Therapies, Inc. Announces Executive Changes	19/03
Intra-Cellular Therapies, Inc. Announces Retirement of Larry Hineline as Chief Financial Officer	19/03
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences	06/03
Intra-Cellular Therapies Insider Sold Shares Worth $1,458,650, According to a Recent SEC Filing	29/02
Intra-Cellular Therapies Insider Sold Shares Worth $1,808,253, According to a Recent SEC Filing	28/02
Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference	27/02
Intra-Cellular Therapies Q4 Loss Narrows, Revenue Increases	22/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Intra-Cellular Therapies, Inc.

Azioni

ITCI

US46116X1019

Altre lingue

Filtri